Medical Examination and Clinical Diagnosis

Application value of artificial intelligence⁃basedretinal microvascular analysis in diagnosis of diabetes complications

  • Rui ZHANG ,
  • Ying ZHOU ,
  • Wenji NI ,
  • Ya HUANG ,
  • Dandan LI ,
  • Tao JIN ,
  • Yong. ZHONG
Expand
  • Department of Health Medicine,Eastern Theater Command General Hospital of PLA,Nanjing 210018,China

Received date: 2023-08-31

  Online published: 2024-04-19

Abstract

Objective To explore the application value of artificial intelligence(AI) based retinal microvascular analysis in the diagnosis of diabetes retinopathy (DR), diabetes nephropathy (DN) and other diabetes complications. Methods From January to December 2022, 305 subjects from the Health Medicine Department and Endocrine Department of the Eastern Theater Command General Hospital of PLA were divided into healthy control group (n = 119), diabetes without DR group (n = 100), and diabetes with DR group (n = 86) according to the condition of diabetes and its complications. The group of diabetes with DR was further divided into the group without DN (n = 50) and the group with DN (n = 36). Clinical data, laboratory test indicators, and fundus photography results of all the subjects were collected. Independent sample t-test, Kruskal Wallis H-test, and logistic regression analysis were used for data analysis. Results There were statistically significant differences in FBG, 2hPBG, HbA1c, central retinal artery equivalent (CRAE), and retinal arteriovenous ratio (AVR) among the three groups (all P < 0.05). In patients with diabetes complicated with DR, there were statistically significant differences in the history of diabetes, total number of bleeding, total area of exudation, maximum area of exudation and total number of exudation between non-DN group and DN group (all P < 0.05). There was correlation between retinal microvascular indicators and diabetic retinopathy. When the total area of retinal hemorrhage, total area of exudation, and maximum area of exudation increased, the risk of diabetic retinopathy increased. Conclusion AI-based retinal microvascular analysis has value in providing prompt indication and assisting with the diagnosis of complications in diabetic patients.

Cite this article

Rui ZHANG , Ying ZHOU , Wenji NI , Ya HUANG , Dandan LI , Tao JIN , Yong. ZHONG . Application value of artificial intelligence⁃basedretinal microvascular analysis in diagnosis of diabetes complications[J]. The Journal of Practical Medicine, 2024 , 40(8) : 1142 -1147 . DOI: 10.3969/j.issn.1006-5725.2024.08.021

References

1 KHARROUBI A T, DARWISH H M. Diabetes mellitus: The epidemic of the century[J]. World J Diabetes, 2015, 6(6):850-867. doi:10.4239/wjd.v6.i6.850
2 MAGLIANO D J, BOYKO E J. IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas [C]. 10th ed. Brussels: International Diabetes Federation, 2021.
3 HAUKKA J, SANDHOLM N, VALO E, et al. Novel linkage peaks discovered for diabetic nephropathy in individuals with type 1 diabetes[J]. Diabetes, 2021, 70(4):986-995. doi:10.2337/db20-0158
4 LV K, CUI C, FAN R, et al. Detection of diabetic patients in people with normal fasting glucose using machine learning[J]. BMC Med, 2023, 21(1):342-354. doi:10.1186/s12916-023-03045-9
5 国家老年医学中心,中华医学会老年医学分会,中国老年保健协会糖尿病专业委员会,等. 中国老年糖尿病诊疗指南(2021年版)[J]. 中华糖尿病杂志,2021,13(1):14-46. doi:10.3760/cma.j.cn115791-20201209-00707
6 中华医学会眼科学分会眼底病学组,中国医师协会眼科医师分会眼底病学组,许迅,等.我国糖尿病视网膜病变临床诊疗指南(2022年)-基于循证医学修订[J]. 中华眼底病杂志, 2023, 39(2):99-124.
7 ALICIC R Z, COX E J, NEUMILLER J J, et al. Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence[J]. Nat Rev Nephrol, 2021, 17(4):227-244. doi:10.1038/s41581-020-00367-2
8 MA Y C, ZUO L, CHEN J H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J]. J Am Soc Nephrol, 2006, 17(10):2937-2944. doi:10.1681/asn.2006040368
9 HUBBARD L D, BROTHERS R J, KING W N, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study[J]. Ophthalmology, 1999, 106(12):2269-2280. doi:10.1016/s0161-6420(99)90525-0
10 GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020:the Right to Sight: an analysis for the Global Burden of Disease Study[J]. Lancet Glob Health, 2021, 9(2):e144-e160.
11 RUIZ O M, RODRIGUES D R, LAVOZ C, et al. Special issue diabetic nephropathy:diagnosis, prevention and treatment[J].Clin Med, 2020, 9(3):813. doi:10.3390/jcm9030813
12 WANG Y, ZHAO H, WANG Q, et al. Chinese herbal medicine in ameliorating diabetic kidney disease via activating autophagy[J]. Diabetes Res, 2019,2019:9030893. doi:10.1155/2019/9030893
13 MORENO J A, GOMEZ-GUERRERO C, MAS S, et al. Targeting inflammation in diabetic nephropathy: a tale of hope[J]. Expert Opin Investig Drug, 2018, 27(11): 917-930. doi:10.1080/13543784.2018.1538352
14 张喆,刘晓怡,叶佩仪,等. 2型糖尿病合并非糖尿病肾脏疾病患者临床及病理特征[J]. 实用医学杂志, 2023, 39(10):1253-1257. doi:10.3969/j.issn.1006-5725.2023.10.011
15 CHEN Y, LIU Q, SHAN Z, et al. Catalpol ameliorates podocyte injury by stabilizing cytoskeleton and enhancing autophagy in diabetic nephropathy[J]. Front Pharmacol, 2019, 10:1477. doi:10.3389/fphar.2019.01477
16 MATOBA K, TAKEDA Y, NAGAI Y, et al. Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease[J].Int J Mol Sci, 2019, 20:3393. doi:10.3390/ijms20143393
17 RAO V, RAO L B V, TAN S H, et al. Diabetic nephropathy: an update on pathogenesis and drug development[J]. Diabetes Metab Syndr,2019, 13(1): 754-762. doi:10.1016/j.dsx.2018.11.054
18 WARREN A M, KNUDSEN S T, COOPER M E. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies[J]. Expert Opin Ther Targets, 2019, 23(7): 579-591. doi:10.1080/14728222.2019.1624721
19 李继红,牛梦琦. 血管内皮生长因子水平对2型糖尿病患者并发视网膜微血管病变的预测价值[J]. 实用医学杂志, 2022, 38(8):1001-1005. doi:10.3969/j.issn.1006-5725.2022.08.017
20 HE J, CAO T, XU F, et al. Artificial intelligence-based screening for diabetic retinopathy at community hospital[J]. Eye, 2020, 34(3):572-576. doi:10.1038/s41433-019-0562-4
21 KLEIN R, MYERS C E, LEE K E, et al. Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy[J]. Arch Ophthalmol, 2012, 130(6): 749-755. doi:10.1001/archophthalmol.2011.2560
22 NGUYEN T T, WANG J J, SHARRETT A R, et al.Relationship of retinal vascular caliber with diabetes and retinopathy:the Multi-Ethnic Study of Atherosclerosis MESA)[J]. Diabetes Care,2008, 31(3):544-549. doi:10.2337/dc07-1528
23 LIEW G, MITCHELL P, WONG T Y, et al. Retinal microvascular signs are associated with chronic kidney disease in persons with and without diabetes[J]. Kidney Blood Press Res, 2012, 35(6):589-594. doi:10.1159/000339173
24 TZIOMALOS K, ATHYROS V G. Diabetic nephropathy:new risk factors and improvements in diagnosis[J]. Rev Diabet Stud, 2015, 12(1/2):110-118. doi:10.1900/rds.2015.12.110
25 IZZEDINE H, BODAGHI B, LAUNAY-VACHER V, et al. Eye and kidney:from clinical findings to genetic explanations[J]. J Am Soc Nephrol, 2003, 14(2):516-529. doi:10.1097/01.asn.0000051705.97966.ad
Outlines

/